Skip to content

Clinical trials

Recruiting Esophageal Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Status: Recruiting Country / region: South Korea Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20212
20231
20245
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
AbbVie1
AstraZeneca1
Bayer1
Daiichi Sankyo1
Eli Lilly and Company1
Jazz Pharmaceuticals1
Medicenna Therapeutics, Inc.1
Pfizer1
SK Life Science, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms15
Stomach Neoplasms9
Ovarian Neoplasms7
Pancreatic Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms5
Urinary Bladder Neoplasms5
Uterine Cervical Neoplasms5
Endometrial Neoplasms4
Squamous Cell Carcinoma of Head and Neck4

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.